Wednesday, August 2, 2017 - 11:02
The Company notifies that the merger between Achieve Life Sciences, Inc. and OncoGenex Pharmaceuticals was successfully closed today and as a result of which the stockholders of Achieve have become the majority stockholders of OncoGenex. OncoGenex has been renamed Achieve Life Sciences (NASDAQ: ACHV).
The company announced that "Cytisine is a drug of global public health importance and the transition of Achieve to the public markets is a critical step in advancing our development program,” commented Rick Stewart, Chairman and CEO of Achieve Life Science.
The whole press release may be found at http://ir.oncogenex.com/releasedetail.cfm?ReleaseID=1030091